Becton, Dickinson and Company (BDX) Stake Maintained by Portland Global Advisors LLC

Northwest Quadrant Wealth Management LLC now owns 1,686 shares of the medical instruments supplier’s stock valued at $332,000 after buying an additional 6 shares during the last quarter. Crestwood Advisors Group LLC bought a new position in Becton, Dickinson and during the first quarter worth approximately $101,000.

Becton, Dickinson and Company (NYSE:BDX) EVP Linda M. Tharby sold 4,695 shares of the stock in a transaction dated Tuesday, August 22nd. The stock had a trading volume of 789,306 shares.

Becton, Dickinson and (NYSE:BDX) last issued its quarterly earnings data on Thursday, August 3rd. It has underperformed by 3.14% the S&P500.

Tekla Capital Management Llc decreased Juno Therapeutics Inc. The Addenda Capital Inc holds 37,353 shares with $3.79 million value, down from 40,563 last quarter. Carbonite now has $519.84M valuation.

Since May 25, 2017, it had 0 insider buys, and 1 sale for $5.35 million activity. About 374,504 shares traded. It is up 14.89% since August 26, 2016 and is uptrending. Jefferies maintained Becton Dickinson and Co (NYSE:BDX) rating on Thursday, March 30.

Comgest Global Investors Sas increased Microsoft Corp (NASDAQ:MSFT) stake by 85,600 shares to 1.70 million valued at $105.60M in 2016Q4. It also upped Ishares (AOM) stake by 10,881 shares and now owns 16,289 shares.

Investors of record on Friday, September 8th will be issued a $0.73 dividend. Its down 0.05, from 0.92 in 2016Q3. It improved, as 52 investors sold BDX shares while 352 reduced holdings. 169.86 million shares or 0.23% less from 170.25 million shares in 2016Q3 were reported. 1,240 are owned by Richard C Young And Company Limited. More interesting news about Becton Dickinson and Co (NYSE:BDX) were released by: Law360.com and their article: “FDA Warning Wire: Becton Dickinson, Ice Pops, Potent Drugs” published on August 23, 2017 as well as Fool.com’s news article titled: “Becton, Dickinson results: The raw numbers” with publication date: August 09, 2017. JP Morgan downgraded Becton Dickinson and Co (NYSE:BDX) on Tuesday, January 3 to “Neutral” rating.

Shares of Becton, Dickinson and (BDX) opened at 198.57 on Thursday. Finally, Parkside Financial Bank & Trust boosted its stake in Becton, Dickinson and by 1.4% in the first quarter. Centre Asset Management Ltd Liability invested in 55,040 shares or 1.76% of the stock. Fayez Sarofim & Company stated it has 2,935 shares. Juno Therapeutics Inc. now has $3.31 billion valuation. 1,625 are held by Los Angeles Cap And Equity Research Incorporated. Segall Bryant & Hamill Limited Liability holds 0.01% of its portfolio in Core Laboratories N.V. (NYSE:CLB) for 3,450 shares. The consensus target price is $173.94 with 6 firms rating the stock a strong buy, 5 firms rating the stock a buy, 7 firms rating the stock a hold, 0 firms rating the stock a underperform, and finally 0 firms rating the stock a sell. Therefore 50% are positive. Shaw Comms had 7 analyst reports since October 20, 2015 according to SRatingsIntel. The company was maintained on Thursday, August 10 by Barclays Capital. The stock of Becton Dickinson and Co (NYSE:BDX) earned “Buy” rating by Piper Jaffray on Tuesday, July 18. The rating was maintained by Argus Research on Wednesday, August 19 with “Buy”. Cowen and Company reiterated an “outperform” rating and set a $230.00 target price (up previously from $200.00) on shares of Becton, Dickinson and in a report on Monday, July 10th. Raymond James upgraded Becton Dickinson and Co (NYSE:BDX) on Friday, June 30 to “Strong Buy” rating. The rating was maintained by Cowen & Co with “Buy” on Thursday, August 17. Cotoia Michael also sold $22,517 worth of TechTarget Inc (NASDAQ:TTGT) on Tuesday, May 2. Carbonite had 8 analyst reports since September 21, 2015 according to SRatingsIntel. Evercore ISI upgraded Becton, Dickinson and from an “in-line” rating to an “outperform” rating and increased their target price for the stock from $186.00 to $200.00 in a report on Monday, April 24th. The company presently has an average rating of “Buy” and an average target price of $195.79.

Investors sentiment is 0.91 in Q4 2016. Its up 0.02, from 0.9 in 2016Q3. It dropped, as 33 investors sold JUNO shares while 37 reduced holdings. 43 funds opened positions while 98 raised stakes. New Jersey-based Blackrock Invest Management Lc has invested 0% in TechTarget Inc (NASDAQ:TTGT). LLC now owns 2,541 shares of the medical instruments supplier’s stock valued at $496,000 after buying an additional 7 shares during the last quarter. Gotham Asset Mngmt Ltd reported 0% stake. Moreover, Cohen Klingenstein Limited Liability Corp has 0.09% invested in Becton Dickinson and Co (NYSE:BDX). Janus Capital Mngmt Limited Co reported 65,482 shares. First National reported 1,501 shares. 1492 Capital Mngmt Llc invested in 0.55% or 43,328 shares. Marble Harbor Investment Counsel Ltd Liability invested in 0.07% or 1,857 shares. Oberweis Asset Management Inc has 109,660 shares. Prelude Cap Mgmt has 0.01% invested in Juno Therapeutics Inc (NASDAQ:JUNO) for 5,044 shares. Dimensional Fund LP has 0% invested in Carbonite Inc (NASDAQ:CARB) for 523,424 shares. Sumitomo Mitsui Asset Mgmt Limited invested in 16,160 shares or 0.05% of the stock. Clearline LP owns 116,200 shares or 0.99% of their USA portfolio. Kcg holds 38,623 shares or 0.02% of its portfolio. Segall Bryant Hamill Ltd Liability Co holds 5,312 shares or 0.02% of its portfolio.

Source link